Company / Current Liabilities
Pasithea Therapeutics Corp. Current Liabilities History
FY2021-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$1.9M
FY2022
5-year range
$447.3K / $1.9M
FY2021-FY2022
Trend
+319.8%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
$2M in FY2022.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, current liabilities increased 319.8% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.26 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | $1.9M | +319.8% |
| FY2021 | $447.3K | - |
As of FY2022 · SEC 10-K · Updated Jun 28, 2026